Back to Authors

Jin, Fengyan

A5042769256 | I194450716

Mayo Clinic

Jilin University

Citations 2

A Simple Risk-Scoring Model for Estimating the Prognostic Impact of 1q Gain in Patients with Newly-Diagnosed Multiple Myeloma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4360-4361

10.1182/blood-2022-168602

TET2 Down-Regulation Confers Bortezomib Resistance in Multiple Myeloma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4185-4186

10.1182/blood-2022-168239